Case Reports
doi: 10.1002/(SICI)1522-726X(199903)46:3<352::AID-CCD21>3.0.CO;2-7.
Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin
Affiliations
- PMID: 10348139
- DOI: 10.1002/(SICI)1522-726X(199903)46:3<352::AID-CCD21>3.0.CO;2-7
Item in Clipboard
Case Reports
Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin
Catheter Cardiovasc Interv.
1999 Mar.
Abstract
Orgaran, a heparinoid, has been used successfully in patients with heparin-induced thrombocytopenia. We report three cases in which Orgaran was combined with the glycoprotein IIbIIa receptor antagonist Reopro during coronary angioplasty. Orgaran was given as a single intravenous bolus of 1500 anti-factor Xa units. No ischemic or hemorrhagic complications occurred during or following the procedure.
Comment in
-
Options to heparin anticoagulation for cardiac interventions.Catheter Cardiovasc Interv. 1999 Mar;46(3):356. doi: 10.1002/(SICI)1522-726X(199903)46:3<356::AID-CCD22>3.0.CO;2-0. Catheter Cardiovasc Interv. 1999. PMID: 10348140 No abstract available.
Similar articles
-
Options to heparin anticoagulation for cardiac interventions.Catheter Cardiovasc Interv. 1999 Mar;46(3):356. doi: 10.1002/(SICI)1522-726X(199903)46:3<356::AID-CCD22>3.0.CO;2-0. Catheter Cardiovasc Interv. 1999. PMID: 10348140 No abstract available.
-
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.Cathet Cardiovasc Diagn. 1998 Nov;45(3):318-22. doi: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2. Cathet Cardiovasc Diagn. 1998. PMID: 9829897
-
[Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].Therapie. 1997 Nov-Dec;52(6):591-7. Therapie. 1997. PMID: 9734113 Clinical Trial. French.
-
Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.Ann Thorac Surg. 1997 Dec;64(6):1815-7. doi: 10.1016/s0003-4975(97)01065-5. Ann Thorac Surg. 1997. PMID: 9436582 Review.
-
Vascular drugs in the new millennium.J Am Coll Surg. 2000 Jul;191(1):76-92. doi: 10.1016/s1072-7515(00)00292-1. J Am Coll Surg. 2000. PMID: 10898187 Review. No abstract available.
Cited by
-
Heparin-induced Thrombocytopenia.Curr Treat Options Cardiovasc Med. 2001 Jun;3(3):215-224. doi: 10.1007/s11936-001-0040-7. Curr Treat Options Cardiovasc Med. 2001. PMID: 11341867
-
Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Curr Cardiol Rep. 2001 Sep;3(5):362-70. doi: 10.1007/s11886-001-0052-7. Curr Cardiol Rep. 2001. PMID: 11504572 Review.
-
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.Curr Cardiol Rep. 2007 Sep;9(5):396-405. doi: 10.1007/BF02938367. Curr Cardiol Rep. 2007. PMID: 17877935 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
